U.S. Professional Services Stock News

ATI Inc. has announced that longtime executive James Robert "Rob" Foster will become Senior Vice President, Finance and Chief Financial Officer on January 1, 2026, succeeding current CFO Don Newman, who will move into a Strategic Advisor role before retiring on March 1, 2026. The choice of an internal leader with both deep operational experience and prior finance leadership signals ATI’s emphasis on tying capital decisions closely to manufacturing performance and long-term contract...

Fortive (FTV) jumped after its Q3 report showed revenue and earnings coming in ahead of expectations, giving investors a reason to revisit a stock that has lagged the broader tech space. See our latest analysis for Fortive. At around $54.80, Fortive’s one month share price return of 6.76 percent and 90 day share price return of 10.55 percent hint at improving momentum. This is the case even though the year to date share price return remains sharply negative and the one year total shareholder...

General American Investors Company, Inc. recently renewed its preferred stock repurchase program, authorizing further buybacks of its 5.95% Cumulative Preferred Stock, Series B, while President and CEO Jeffrey W. Priest purchased 60 shares of this preferred issue on December 8, 2025. Together, the renewed buyback authorization and insider purchase highlight management’s emphasis on capital structure management and alignment with preferred shareholders’ interests. Next, we will examine how...

If you are wondering whether OUTFRONT Media is still a bargain after its run up, or if you have missed the bus, this breakdown will help you assess whether the current price really makes sense. The stock has quietly delivered a 1.6% gain over the last week and 12.9% over the last month. It is now up 31.8% year to date, with a 31.2% gain over the past year hinting that investors are warming up to its story. Investor interest has been driven by a mix of strategic moves in its transit and...

In recent days, analysts have highlighted CubeSmart’s improving self-storage fundamentals, pointing to stabilizing market rents, raised guidance, and strengthening trends in key urban markets such as New York City. The contrasting analyst opinions, with some citing muted self-storage demand while others name CubeSmart a top recovery idea for 2026, underscore how sensitive the company’s outlook is to shifts in sector pricing and occupancy. Next, we’ll examine how RBC’s emphasis on CubeSmart’s...

If you are wondering whether Crescent Energy is a quietly mispriced energy play or a value trap in the making, you are not alone. This breakdown aims to cut through the noise. Despite trading around $9.76, the stock has climbed 0.6% over the last week and 8.9% over the past month, even though it is still down 34.4% year to date and 30.5% over the last year. Much of this recent bounce has come as investors rotate back into select energy names and reassess companies with scale, cash flow and...

If you have ever wondered whether Colgate Palmolive is quietly becoming a bargain while markets chase flashier names, you are exactly the kind of investor this breakdown is for. The stock has drifted lower, with shares at around $77.76 and returns of 5.2% over 3 years and just 2.9% over 5 years. This hints at subdued expectations rather than runaway optimism. Recently, investor attention has focused on Colgate Palmolive's push into higher margin premium oral care products and its broader...

If you are wondering whether PROG Holdings is quietly turning into a value opportunity while most investors look the other way, this article will walk through whether the current share price really matches the business underneath. Despite being down 26.4% year to date and 32.7% over the last year, the stock has bounced 5.4% in the last week and 10.5% over the last month, all against a backdrop of a still strong 78.6% gain over three years. Recent headlines have focused on PROG Holdings...

SEALSQ Corp., together with WISeSat.Space, recently reported the successful launch of its latest WISeSat satellite aboard a SpaceX Falcon 9 Transporter 16, adding software-defined radio, higher data-rate communications, and secure IoT capabilities to its growing constellation. This mission advances SEALSQ’s ambition to merge space, cybersecurity, blockchain, and quantum-safe services, including future quantum-resistant key distribution for critical infrastructure and secure onboarding of...

Earlier this month, Alphabet’s Google confirmed that its renewed push into AI-powered smart glasses includes a multi-year collaboration with Warby Parker, aiming to launch lightweight Android XR- and Gemini-enabled eyewear in 2026 with both display and audio-focused models. The partnership goes beyond co-branding: Google has committed up to US$150 million tied to product milestones, while Warby Parker is investing a similar amount and gaining an equity stake, effectively repositioning the...

The latest pop in JBT Marel (JBTM) came right after the Federal Reserve trimmed rates and leaned dovish, a backdrop that pushed industrial names higher and sharpened investor focus on JBTM’s longer term trajectory. See our latest analysis for JBT Marel. That surge slots into an already impressive run, with the share price now at $153.8 and a year to date share price return of 22.73 percent alongside a 3 year total shareholder return of 71.98 percent. This signals that momentum is clearly...

Packaging Corporation of America has announced it will permanently shut down the No. 2 paper machine and kraft pulping facilities at its Wallula, Washington mill, cutting annual containerboard capacity there by 250,000 tons while investing in the remaining recycled-based operations and incurring an estimated US$205 million in restructuring charges spread across late 2025 and early 2026. At the same time, the company plans to lower Wallula’s production costs by about US$125 per ton from 2025...

If you are wondering whether Cencora is still worth buying after such a strong run, or if the prudent move now is to wait for a better entry price, you are in the right place. The stock has pulled back around 6.5% over the last month, but is still up 51.6% year to date and about 48.1% over the past year, which keeps the long term uptrend very much intact. Recent headlines have focused on Cencora's ongoing role in streamlining pharmaceutical distribution and expanding its specialty services...

If you are wondering whether Rubrik at around $89.91 is still a smart buy after its run up, or if you are late to the party, this breakdown will help you understand what the market is really pricing in. Rubrik has jumped 27.7% in the last week and is up 35.5% year to date, with a 21.2% gain over the past year, which indicates that investor expectations have shifted quickly. Recent headlines have focused on Rubrik's expanding footprint in cyber resilience and data security, as enterprises...

M&T Bank Corporation recently reduced its prime lending rate to 6.75% from 7.00%, a move that directly affects borrowing costs for many of its commercial and retail customers across its eastern U.S. footprint. This rate cut may influence M&T Bank’s interest income profile and funding mix, intersecting with prior expectations around its net interest margins and capital deployment. We’ll now explore how this prime rate reduction reshapes M&T Bank’s investment narrative around margins, growth,...

In early December 2025, Polaris Slingshot launched its 2026 model-year lineup, including a limited-edition Grand Touring trim, new premium iridescent paint schemes, upgraded wheel designs, and an optional subscription-based RIDE COMMAND+ connected services package. This refresh pushes Slingshot further into higher-end, feature-rich territory, potentially reinforcing Polaris’ premium positioning and deepening customer engagement through digital services. We’ll now examine how the...

CSX (CSX) shares have quietly climbed in the past month, and that move has investors asking whether this rail giant’s recent momentum reflects improving fundamentals or simply a broader market tailwind. See our latest analysis for CSX. Zooming out, CSX’s recent climb to a share price of $37.09 extends a steady upward trend, with a roughly mid-teens year to date share price return and a double digit one year total shareholder return that together signal gradually improving sentiment rather...

Middleby (MIDD) just caught fresh attention after Jefferies shifted to a Buy rating, pointing to momentum in its Commercial Foodservice business, healthier margins, and ongoing support from share repurchases and insider buying. See our latest analysis for Middleby. The Jefferies upgrade seems to have lit a fire under the stock, with a 1 day share price return of 9.27 percent and a 7 day share price return of 17.56 percent, even though the 1 year total shareholder return is still slightly...

In early December 2025, BKV Corporation completed a follow-on equity offering of US$156,000,000, issuing 6,000,000 common shares at US$26 each, reflecting a US$1.17 per-share discount to the prior price range. The deal coincided with upbeat analyst sentiment and upward earnings estimate revisions, suggesting investors viewed the capital raise as supportive of BKV’s growth plans rather than dilutive risk. Next, we’ll examine how this upbeat analyst sentiment around BKV’s successfully...

If you have been wondering whether Citizens Financial Group is still a bargain after its latest run up, you are not alone. This article is going to unpack exactly what you might be paying for at today’s price. The stock has climbed 5.0% over the last week, 11.7% over the past month, and is now up 34.1% year to date, building on a 31.3% 1 year gain and more than doubling investors’ money over 5 years with a 104.4% total return. Recent moves have been driven by a mix of improving sentiment...

Biohaven Ltd. recently presented clinical safety and efficacy data from its novel Trop2-directed antibody-drug conjugate BHV-1510, in combination with Regeneron’s anti-PD-1 cemiplimab, at the 2025 ESMO Immuno-Oncology Congress in London, showing meaningful response rates and manageable safety across several tumor types. The data, including strong objective response rates in non-small cell lung, endometrial, urothelial and triple negative breast cancers, underscores Biohaven’s growing...

Wondering if Medical Properties Trust at around $5.50 is a bargain or a value trap? You are not alone. This stock has become a lightning rod for income investors trying to separate recovery potential from real risk. After a brutal multi year slide, the shares are still down 39.6% over 3 years and 61.6% over 5 years, but they have bounced 37.1% year to date and 43.6% over the last year, including an 11.1% gain in the past month despite a minor 2.0% pullback this week. That rebound has played...

If you are wondering whether Heidrick & Struggles International is still a smart buy after such a strong run, you are not alone. This is exactly what we are going to unpack here. The stock has climbed 33.9% year to date and is up 30.4% over the last year, while longer term holders have seen gains of 108.8% over 3 years and 122.8% over 5 years, all from a recent close of $59.01. Those gains have come as investors have warmed to the company’s positioning in higher value advisory and leadership...

BofA Securities just cooled on PROCEPT BioRobotics (PRCT), downgrading the stock to neutral after flagging slower utilization of its aquablation systems and softer system sales as hospital capital budgets tighten. See our latest analysis for PROCEPT BioRobotics. Investors have already been wrestling with this shift in sentiment, with a 1 month share price return of 13.94 percent offering only a brief rebound against a year to date share price loss of 57.06 percent and a 1 year total...